Thompson Brian R's Form 4 filing
UnitedHealth Group Inc (UNH) · filed Feb 20, 2024
- Accession no.
- 0000731766-24-000042
- Filed
- Feb 20, 2024
- Trade date
- Feb 16, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 11 non-derivative transactions and 5 derivative transactions. Open-market sales total $15.1M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Brian RCIK 0001857198 | Officer (CEO, UnitedHealthcare) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Common Stock | MOption exerciseAcquired | +6,535 | $160.31 | +$1,047,625.85 | 38,162.69 | Direct | |
| Feb 16, 2024 | Common Stock | FTax withholdingDisposed | −4,074 | $521.07 | −$2,122,839.18 | 34,088.69 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseAcquired | +17,681 | $226.64 | +$4,007,221.84 | 51,769.69 | Direct | |
| Feb 16, 2024 | Common Stock | FTax withholdingDisposed | −12,246 | $521.13 | −$6,381,757.98 | 39,523.69 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseAcquired | +21,377 | $262.98 | +$5,621,723.46 | 60,900.69 | Direct | |
| Feb 16, 2024 | Common Stock | FTax withholdingDisposed | −15,616 | $521.24 | −$8,139,683.84 | 45,284.69 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseAcquired | +13,008 | $243.20 | +$3,163,545.6 | 58,292.69 | Direct | |
| Feb 16, 2024 | Common Stock | FTax withholdingDisposed | −9,234 | $521.18 | −$4,812,576.12 | 49,058.69 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseAcquired | +23,747 | $302.20 | +$7,176,343.4 | 72,805.69 | Direct | |
| Feb 16, 2024 | Common Stock | FTax withholdingDisposed | −18,320 | $521.18 | −$9,548,017.6 | 54,485.69 | Direct | |
| Feb 16, 2024 | Common Stock | SSaleDisposed | −28,943 | $521.00F1 | −$15,079,303 | 25,542.69 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2024 | Common Stock | MOption exerciseDisposed | −6,535 | $0.00 | $0 | 0 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseDisposed | −17,681 | $0.00 | $0 | 0 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseDisposed | −21,377 | $0.00 | $0 | 0 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseDisposed | −13,008 | $0.00 | $0 | 0 | Direct | |
| Feb 16, 2024 | Common Stock | MOption exerciseDisposed | −23,747 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades ranging from $520.320 to $522.420 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.